Kenneth A. Beckman, M.D., doesn’t see insurers as standing in the way of patients getting treated with the “epi-on” approach ...

In an interview conducted by Ophthalmology Times on behalf of Managed Healthcare Executive, Beckman listed some of the ...

Beckman said it is important to treat keratoconus with corneal collagen crosslinking early to prevent vision loss, although ...

Researchers of the National Eye Institute found that the supplement—now known as the AREDS formula, containing vitamins C and ...

Bandyopadhyay and colleagues found that new T1D registrations were most likely to come from people under the age of 40, ...

Conflicting studies on GLP-1 drugs’ vision impacts prompt calls for baseline eye exams and monitoring.

Cobenfy represents a breakthrough schizophrenia treatment with a novel mechanism, but limited long-term data requires ...

More than two decades after the September 11 attacks, new research suggests that responders who worked amid the World Trade Center (WTC) dust and debris face nearly a 3-fold higher incidence of lung ...

The FDA has approved Genentech’s Gazyva (obinutuzumab) for the treatment of lupus nephritis in adults, according to a news release published today. Gazyva is the first and only anti-CD20 monoclonal ...

The new treatments Gilhooley referred to are calcitonin gene-related peptide (CGRP) inhibitors, a class that includes ...

Pain from around or behind the eyes is a feature of many headaches. But that doesn't mean that there aren't painful eye ...

Gilhooley noted that the large trigeminal nerve that innervates the face and the scalp also branches out to the eye.